El interés en corto de Sensient Technologies da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Sensient Technologies. Los datos de interés en corto se actualizan cada dos semanas.

Sensient Technologies (NYSE:SXT) Bolsa, Informe de interés en corto

Sensient Technologies

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

Sensient Technologies Corporation Common Stock

Sensient Technologies Corp

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. - Warrant

WIIM

Sensient Technologies shares are trading lower after the company reported a Q4 revenue miss and issued FY25 EPS guidance below estimates.

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="3" rowspan="1">2025 OUTLOOK</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Metric</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Current Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Local Currency Revenue(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Mid-Single-Digit Growth</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Local Currency Adjusted EBITDA(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Mid-Single-Digit to High Single-Digit Growth</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diluted EPS (GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Between $3.05 and $3.15&#x2A;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Local Currency Adjusted Diluted EPS(1)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">High Single-Digit to Double-Digit Growth</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3" rowspan="1">&#x2A;Includes approximately 13 cents of Portfolio Optimization Plan costs and 10 to 15 cents of foreign currency headwinds based on current exchange rates</td>
</tr>
</tbody>
</table>
</figure>

Earnings

News

Guidance

Sensient Technologies 2025 EPS Guidance At $3.05-$3.15 (Vs. $3.39 Est.); Sees Revenue Growth Of Mid-Single-Digit And Adj. EPS Growth Of High Single-Digit To Double-Digit

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.64 by 1.56 percent. This is a 27.45 percent increase over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $376.420 million which missed the analyst consensus estimate of $377.550 million by 0.30 percent. This is a 7.76 percent increase over sales of $349.302 million the same period last year.

Earnings Beats

Earnings Misses

Sensient Technologies Q4 2024 Adj. EPS $0.65 Beats $0.64 Estimate, Sales $376.420M Miss $377.550M Estimate

<h3>Companies Reporting Before The Bell</h3>
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is likely to report quarterly loss at $0.16 per share on revenue of $1.39 billion. 
• Newmark Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRK#NASDAQ">NMRK</a>) is likely to report quarterly earnings at $0.48 per share on revenue of $790.76 million. 
• Enbridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENB#NYSE">ENB</a>) is likely to report quarterly earnings at $0.52 per share on revenue of $4.78 billion. 
• Treehouse Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) is projected to report quarterly earnings at $0.97 per share on revenue of $907.90 million. 
• Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) is expected to report quarterly loss at $2.72 per share on revenue of $951.09 million. 
• TC Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRP#NYSE">TRP</a>) is expected to report quarterly earnings at $0.68 per share on revenue of $2.43 billion. 
• Essent Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESNT#NYSE">ESNT</a>) is estimated to report quarterly earnings at $1.65 per share on revenue of $313.88 million. 
• Fortis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTS#NYSE">FTS</a>) is likely to report quarterly earnings at $0.57 per share on revenue of $2.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is estimated to report quarterly earnings at $1.52 per share on revenue of $10.32 billion. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $1.52 per share on revenue of $10.32 billion. 
• Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $199.80 million. 
• AMC Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) is estimated to report quarterly earnings at $1.05 per share on revenue of $611.26 million. 
• Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) is likely to report earnings for its third quarter. 
• BGC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>) is likely to report quarterly earnings at $0.25 per share on revenue of $570.00 million. 
• Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $663.32 million. 
• Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is expected to report quarterly earnings at $0.64 per share on revenue of $375.10 million. 
<h3>Companies Reporting After The Bell</h3>
• Clipper Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLPR#NYSE">CLPR</a>) is likely to report quarterly earnings at $0.14 per share on revenue of $38.70 million. 
• SolarBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUUN#NASDAQ">SUUN</a>) is expected to report quarterly loss at $0.01 per share on revenue of $16.44 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMCX

CLPR

ESNT

MRNA

NMRK

SUUN

ZCAR

Earnings Scheduled For February 14, 2025

Sensient Technologies Reaffirmed FY24 EPS Guidance At $2.77-$2.87, Revised Revenue To Grow At High Single-Digit Growth	(Vs. Mid-To High Single-Digit Growth Prior) Rate On Local Currency Basis

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) reported quarterly earnings of $0.80 per share which met the analyst consensus estimate. The company reported quarterly sales of $392.613 million which beat the analyst consensus estimate of $390.700 million by 0.49 percent. This is a 7.91 percent increase over sales of $363.829 million the same period last year.

Sensient Technologies Q3 2024 Adj. EPS $0.80, Inline, Sales $392.613M Beat $390.700M Estimate

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is gearing up to announce its quarterly earnings on Friday, 2024-10-25. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Sensient Technologies will report an earnings per share (EPS) of $0.80.
Sensient Technologies bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.05, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Sensient Technologies's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.82</td>
<td>0.70</td>
<td>0.55</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.79</td>
<td>0.51</td>
<td>0.75</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729792835_0_0.png" alt="eps graph" />
<h3>Performance of Sensient Technologies Shares</h3>
Shares of Sensient Technologies were trading at $77.09 as of October 23. Over the last 52-week period, shares are up 37.79%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Views on Sensient Technologies</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Sensient Technologies.
With 1 analyst ratings, Sensient Technologies has a consensus rating of Outperform. The average one-year price target is $85.0, indicating a potential 10.26% upside.
<h3>Analyzing Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Quaker Houghton, Ashland and Avient, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>For Quaker Houghton, analysts project an Buy trajectory, with an average 1-year price target of $192.5, indicating a potential 149.71% upside.</li>
<li>Ashland is maintaining an Neutral status according to analysts, with an average 1-year price target of $97.0, indicating a potential 25.83% upside.</li>
<li>Avient received a Outperform consensus from analysts, with an average 1-year price target of $55.0, implying a potential 28.65% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Quaker Houghton, Ashland and Avient are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sensient Technologies</td>
<td>Outperform</td>
<td>7.80%</td>
<td>$130.72M</td>
<td>2.92%</td>
</tr>
<tr>
<td>Quaker Houghton</td>
<td>Buy</td>
<td>-6.43%</td>
<td>$175.72M</td>
<td>2.50%</td>
</tr>
<tr>
<td>Ashland</td>
<td>Neutral</td>
<td>-0.37%</td>
<td>$186M</td>
<td>0.20%</td>
</tr>
<tr>
<td>Avient</td>
<td>Outperform</td>
<td>3.07%</td>
<td>$257.60M</td>
<td>1.45%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Sensient Technologies ranks first in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it ranks second in Consensus rating and third in Return on Equity.
<h3>Discovering Sensient Technologies: A Closer Look</h3>
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors &amp; Extracts Group, the Color Group, and the Asia Pacific Group.
<h3>Sensient Technologies: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Sensient Technologies's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.8% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Sensient Technologies's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 7.67%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Sensient Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.92%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.55%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.63, Sensient Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/SXT/earnings">To track all earnings releases for Sensient Technologies visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of Sensient Technologies's Earnings

Baird analyst Ghansham Panjabi maintains Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) with a Outperform and raises the price target from $80 to $85.

Price Target

Analyst Ratings

Baird Maintains Outperform on Sensient Technologies, Raises Price Target to $85

Sensient Technologies Lowered FY24 Diluted EPS Guidance To $2.77-$2.87 (From $2.80-$2.90 Earlier), Revised Revenue To Grow At Mid-To High Single-Digit Growth (Vs. Mid-Single-Digit Prior) Rate On Local Currency Basis

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) reported quarterly earnings of $0.77 per share which missed the analyst consensus estimate of $0.82 by 6.1 percent. The company reported quarterly sales of $403.525 million which beat the analyst consensus estimate of $395.000 million by 2.16 percent. This is a 7.80 percent increase over sales of $374.313 million the same period last year.

Sensient Technologies Q2 2024 Adj EPS $0.77 Misses $0.82 Estimate, Sales $403.525M Beat $395.000M Estimate

It was reported on May 21, that ESSIE WHITELAW, Board Member at Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) executed a significant insider sell, according to an SEC filing.
What Happened: WHITELAW's decision to sell 1,037 shares of Sensient Technologies was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000310142/000112760224016155//Archives/edgar/data/310142/000112760224016155/0001127602-24-016155-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $78,552.
During Wednesday's morning session, Sensient Technologies shares down by 0.0%, currently priced at $75.99.
<h3>Discovering Sensient Technologies: A Closer Look</h3>
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors &amp; Extracts Group, the Color Group, and the Asia Pacific Group.
<h3>Financial Insights: Sensient Technologies</h3>
Revenue Growth: Sensient Technologies's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 4.24%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: With a low gross margin of 32.9%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Sensient Technologies's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.73.
</li>
</ul>
Debt Management: Sensient Technologies's debt-to-equity ratio is below the industry average. With a ratio of 0.62, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 35.51 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 2.18 is lower than the industry average, implying a discounted valuation for Sensient Technologies's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 18.2 positions the company as being more valued compared to industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000310142">Check Out The Full List Of Sensient Technologies's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

ESSIE WHITELAW Takes Money Off The Table, Sells $78K In Sensient Technologies Stock

Baird analyst Ghansham Panjabi maintains Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) with a Outperform and raises the price target from $70 to $80.

Baird Maintains Outperform on Sensient Technologies, Raises Price Target to $80

Sensient Technologies Reiterates FY24 Diluted Earnings Per Share Of $2.80-$2.90 Vs. $2.98 Estimate, Projects Revenue To Grow At Mid-Single-Digit Rate On Local Currency Basis

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.70 by 12.86 percent. This is a 1.25 percent decrease over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $384.67 million which beat the analyst consensus estimate of $367.80 million by 4.59 percent. This is a 4.24 percent increase over sales of $369.01 million the same period last year.

Sensient Technologies Q1 Adj $0.79 Beats $0.70 Estimate, Sales $384.67M Beat $367.80M Estimate

Shares of Take-Two Interactive Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttwo#NASDAQ">TTWO</a>) fell sharply during Friday&rsquo;s session following third-quarter results.
Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $5.55 billion earlier.
Take-Two Interactive Software shares dipped 8.8% to $154.69 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) shares jumped 267% to $0.1990. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware.</li>
<li>TOP Financial Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/top#NASDAQ">TOP</a>) gained 87.55% to $6.13.</li>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares climbed 66% to $0.1932 after the company disclosed completion of financing to support restructuring process.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) jumped 47.3% to $4.24 following second-quarter results.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares climbed 46% to $1.6099 after jumping over 16% on Thursday.</li>
<li>Intelligent Living Application Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilag#NASDAQ">ILAG</a>) gained 45.5% to $0.6851 after surging around 24% on Thursday.</li>
<li>Green Giant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gge#NASDAQ">GGE</a>) shares rose 44.4% to $0.0535 after gaining 25% on Thursday.</li>
<li>Better Choice Company Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bttr#NYSE">BTTR</a>) gained 35% to $0.2379. Better Choice acquired Aimia Pet Healthco.</li>
<li>Masonite International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/door#NYSE">DOOR</a>) surged 34.5% to $129.99 after Owens Corning announced it will acquire the company for $3.9 billion.</li>
<li>Cloudflare, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/net#NYSE">NET</a>) rose 23.5% to $111.49 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares gained 22% to $12.81 after the company reported a year-over-year increase in first-quarter GAAP EPS and better-than-expected sales results.</li>
<li>Centessa Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnta#NASDAQ">CNTA</a>) climbed 20.5% to $8.99. Centessa Pharmaceuticals will present additional 52-weeks continuous treatment data from third year ongoing Phase 2a study of SerpinPC for treatment of hemophilia at 17th Annual Congress of European Association for Haemophilia and Allied Disorders.</li>
<li>IGM Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) gained 19.2% to $15.44.</li>
<li>Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) rose 18.8% to $0.4814.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngvc#NYSE">NGVC</a>) gained 18.2% to $17.51 following quarterly results.</li>
<li>Soho House &amp; Co Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shco#NYSE">SHCO</a>) rose 15.7% to $5.79. Soho House announced its board evaluated certain strategic transactions in the fall of 2023.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) gained 13.1% to $5.77.</li>
<li>Matrix Service Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtrx#NASDAQ">MTRX</a>) rose 13.1% to $12.82.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) gained 12.6% to $7.07.</li>
<li>Central Garden &amp; Pet Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) rose 10.4% to $43.03. Central Garden &amp; Pet reported better-than-expected first-quarter financial results.</li>
<li>Impinj, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pi#NASDAQ">PI</a>) gained 10.2% to $117.18 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 8.2% to $5.44. B of A Securities analyst Tazeen Ahmad initiated coverage on Ocular Therapeutix with a Buy rating and announced a price target of $15.</li>
<li>Mueller Water Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mwa#NYSE">MWA</a>) gained 8% to $14.99 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synlogic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sybx#NASDAQ">SYBX</a>) fell 53.3% to $1.61 after the company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.</li>
<li>The Children&#39;s Place, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plce#NASDAQ">PLCE</a>) shares fell 52.7% to $9.34 after the company said it expects fourth-quarter net sales to be roughly $454 million to $456 million, versus its prior guidance of $460 million to $465 million, and below the estimate of $462.88 million.</li>
<li>BioXcel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btai#NASDAQ">BTAI</a>) fell 33.7% to $2.4882 after the company announced a proposed public offering.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) declined 33.5% to $8.62.</li>
<li>EMCORE Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/emkr#NASDAQ">EMKR</a>) fell 32% to $0.4275 after posting weak quarterly results.</li>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) declined 31% to $0.7172.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares fell 30% to $0.3791 after climbing over 96% on Thursday.</li>
<li>Lantronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrx#NASDAQ">LTRX</a>) fell 28.8% to $4.1350 following weak sales.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares declined 27.4% to $20.81 after jumping over 59% on Thursday. The company announced it planned to join the Communications Industry Association. HOLO intends to join the Communications Industry Association to foster information technology innovation.</li>
<li>eGain Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egan#NASDAQ">EGAN</a>) fell 24.4% to $5.77 following second-quarter results.</li>
<li>AMC Networks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amcx#NASDAQ">AMCX</a>) declined 19.1% to $13.78 following weak earnings.</li>
<li>Virco Mfg. Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virc#NASDAQ">VIRC</a>) dipped 18.6% to $9.48.</li>
<li>Expedia Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/expe#NASDAQ">EXPE</a>) declined 17.6% to $131.38 after the company reported fourth-quarter financial results and named Ariane Gorin as CEO.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) fell 12.3% to $7.50.</li>
<li>Newell Brands Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwl#NASDAQ">NWL</a>) declined 11.8% to $7.45 following quarterly results.</li>
<li>Pinterest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pins#NYSE">PINS</a>) shares declined 11.4% to $36.07. Pinterest reported upbeat earnings for its fourth quarter, while sales missed estimates. The company said it sees first-quarter revenue in the range of $690 million to $705 million versus estimates of $702.36 million.</li>
<li>BILL Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) fell 11% to $67.40 following quarterly results.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) shares fell 10.6% to $43.98 after the company reported second-quarter financial results.</li>
<li>IBEX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibex#NASDAQ">IBEX</a>) fell 10.2% to $15.61.</li>
<li>Sensient Technologies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sxt#NYSE">SXT</a>) fell 9.6% to $56.62 following weak earnings.</li>
<li>Owens Corning (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oc#NYSE">OC</a>) fell 6.9% to $148.43 after the company announced an agreement to acquire Masonite for $3.9 billion.</li>
<li>Magna International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mga#NYSE">MGA</a>) declined 6.5% to $54.89 after the company reported mixed quarterly results.</li>
<li>Illumina, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ilmn#NASDAQ">ILMN</a>) shares declined 2.7% to $139.45 following fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37034937/bitcoin-surpasses-47-000-thorchain-emerges-as-top-gainer"> Bitcoin Tops $47,000; THORChain Emerges As Top Gainer </a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

AFRM

BILL

BTAI

BTTR

CENT

CLSK

CNTA

DOOR

EGAN

EMKR

EXPE

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBEX

IGMS

ILAG

ILMN

Intelligent Bio Solutions Inc. - Common Stock

INBS

IREN

LTRX

MLGO

MTRX

NGVC

NSTG

OCUL

PINS

PLCE

RNLX

SHCO

STRM

SUNW

SYBX

TCBP

TERN

TTWO

VIRC

ZJYL

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Sensient Technologies shares are trading lower after the company reported worse-than-expected Q4 financial results.

Sensient Technologies Expects 2024 Revenue, Adjusted EBITDA And Adjusted EPS To Grow At Low-To-Mid Single-Digit Rate On Local Currency Basis

Management

Sensient Technologies' Senior Vice President And CFO Stephen Rolfs Intends To Retire Effective June 30, 2024; Tobin Tornehl To Be Named CFO Upon Rolfs' Retirement

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) reported quarterly Adj earnings of $0.51 per share which missed the analyst consensus estimate of $0.55 by 7.27 percent. This is a 20.31 percent decrease over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $349.30 million which missed the analyst consensus estimate of $371.00 million by 5.85 percent. This is a 0.16 percent increase over sales of $348.74 million the same period last year.

Sensient Technologies Q4 Adj EPS $0.51 Misses $0.55 Estimate, Sales $349.30M Miss $371.00M Estimate

Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is set to give its latest quarterly earnings report on Friday, 2024-02-09. Here's what investors need to know before the announcement.
Analysts estimate that Sensient Technologies will report an earnings per share (EPS) of $0.55. 
Sensient Technologies bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 0.0% drop in the share price the next day.
Here's a look at Sensient Technologies's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.75</td>
<td>0.88</td>
<td>0.78</td>
<td>0.70</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.75</td>
<td>0.81</td>
<td>0.80</td>
<td>0.64</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.47%</td>
<td>-5.74%</td>
<td>1.03%</td>
<td>2.22%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1707404441_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Sensient Technologies were trading at $63.06 as of February 07. Over the last 52-week period, shares are down 14.9%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/SXT/earnings">To track all earnings releases for Sensient Technologies visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Sensient Technologies

Press Releases

Sensient Announces Conference Call

Sensient Declares Dividend

Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2024 and Raises Full Year Guidance

Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2024

Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2024

Comments

Sensient Technologies

Interés en corto

Sensient Technologies (NYSE:SXT) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL